vs
Amarin Corp plc（AMRN）与英美资源集团（AMSC）财务数据对比。点击上方公司名可切换其他公司
英美资源集团的季度营收约是Amarin Corp plc的1.7倍（$74.5M vs $45.1M），英美资源集团净利率更高（158.1% vs -23.3%，领先181.3%），英美资源集团同比增速更快（21.4% vs 7.0%），过去两年英美资源集团的营收复合增速更高（33.2% vs -18.3%）
Amarin是一家1993年成立的爱裔美籍生物制药企业，总部分别设于爱尔兰都柏林与美国新泽西州布里奇沃特。该企业专注研发及销售心血管疾病治疗药物，已推出处方级Omega-3脂肪酸药物Vascepa（AMR-101）。
英美资源集团是一家总部位于英国伦敦的跨国矿业企业，是全球最大的铂金生产商，产量约占全球总产出的40%，同时也是钻石、铜、镍、铁矿石、多卤石、炼焦煤的主要供应商，业务布局覆盖非洲、亚洲、大洋洲、欧洲、南北美洲多个地区。
AMRN vs AMSC — 直观对比
营收规模更大
AMSC
是对方的1.7倍
$45.1M
营收增速更快
AMSC
高出14.4%
7.0%
净利率更高
AMSC
高出181.3%
-23.3%
两年增速更快
AMSC
近两年复合增速
-18.3%
损益表 — Q1 FY2026 vs Q3 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $45.1M | $74.5M |
| 净利润 | $-10.5M | $117.8M |
| 毛利率 | — | 30.7% |
| 营业利润率 | 35.5% | 4.5% |
| 净利率 | -23.3% | 158.1% |
| 营收同比 | 7.0% | 21.4% |
| 净利润同比 | 33.0% | 4679.1% |
| 每股收益（稀释后） | — | $2.62 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AMRNAMSC
| Q1 26 | $45.1M | — | ||
| Q4 25 | $49.2M | $74.5M | ||
| Q3 25 | $49.7M | $65.9M | ||
| Q2 25 | $72.7M | $72.4M | ||
| Q1 25 | $42.0M | $66.7M | ||
| Q4 24 | $62.3M | $61.4M | ||
| Q3 24 | $42.3M | $54.5M | ||
| Q2 24 | $67.5M | $40.3M |
净利润AMRNAMSC
| Q1 26 | $-10.5M | — | ||
| Q4 25 | $-1.2M | $117.8M | ||
| Q3 25 | $-7.7M | $4.8M | ||
| Q2 25 | $-14.1M | $6.7M | ||
| Q1 25 | $-15.7M | $1.2M | ||
| Q4 24 | $-48.6M | $2.5M | ||
| Q3 24 | $-25.1M | $4.9M | ||
| Q2 24 | $1.5M | $-2.5M |
毛利率AMRNAMSC
| Q1 26 | — | — | ||
| Q4 25 | 47.1% | 30.7% | ||
| Q3 25 | 44.7% | 31.0% | ||
| Q2 25 | 69.2% | 33.8% | ||
| Q1 25 | 59.8% | 26.5% | ||
| Q4 24 | -15.4% | 26.6% | ||
| Q3 24 | 38.5% | 28.7% | ||
| Q2 24 | 63.4% | 30.3% |
营业利润率AMRNAMSC
| Q1 26 | 35.5% | — | ||
| Q4 25 | -12.9% | 4.5% | ||
| Q3 25 | -22.4% | 4.5% | ||
| Q2 25 | -22.0% | 7.8% | ||
| Q1 25 | -39.9% | 2.5% | ||
| Q4 24 | -84.3% | 2.1% | ||
| Q3 24 | -59.5% | -1.4% | ||
| Q2 24 | -0.8% | -8.2% |
净利率AMRNAMSC
| Q1 26 | -23.3% | — | ||
| Q4 25 | -2.5% | 158.1% | ||
| Q3 25 | -15.6% | 7.2% | ||
| Q2 25 | -19.4% | 9.3% | ||
| Q1 25 | -37.4% | 1.8% | ||
| Q4 24 | -78.0% | 4.0% | ||
| Q3 24 | -59.4% | 9.0% | ||
| Q2 24 | 2.3% | -6.3% |
每股收益（稀释后）AMRNAMSC
| Q1 26 | — | — | ||
| Q4 25 | $0.00 | $2.62 | ||
| Q3 25 | $-0.02 | $0.11 | ||
| Q2 25 | $-0.03 | $0.17 | ||
| Q1 25 | $-0.04 | $0.04 | ||
| Q4 24 | $-0.12 | $0.06 | ||
| Q3 24 | $-0.06 | $0.13 | ||
| Q2 24 | $0.00 | $-0.07 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $307.8M | $141.1M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | — | $536.8M |
| 总资产 | $645.8M | $719.5M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资AMRNAMSC
| Q1 26 | $307.8M | — | ||
| Q4 25 | $302.6M | $141.1M | ||
| Q3 25 | $286.6M | $212.9M | ||
| Q2 25 | $298.7M | $207.9M | ||
| Q1 25 | $281.8M | $79.5M | ||
| Q4 24 | $294.2M | $75.2M | ||
| Q3 24 | $305.7M | $72.1M | ||
| Q2 24 | $306.7M | $93.5M |
股东权益AMRNAMSC
| Q1 26 | — | — | ||
| Q4 25 | $459.3M | $536.8M | ||
| Q3 25 | $458.9M | $342.2M | ||
| Q2 25 | $464.9M | $333.1M | ||
| Q1 25 | $473.7M | $197.1M | ||
| Q4 24 | $486.2M | $192.7M | ||
| Q3 24 | $531.4M | $187.0M | ||
| Q2 24 | $551.9M | $143.3M |
总资产AMRNAMSC
| Q1 26 | $645.8M | — | ||
| Q4 25 | $670.8M | $719.5M | ||
| Q3 25 | $659.8M | $445.6M | ||
| Q2 25 | $670.1M | $452.8M | ||
| Q1 25 | $655.7M | $310.5M | ||
| Q4 24 | $685.3M | $310.3M | ||
| Q3 24 | $750.6M | $298.4M | ||
| Q2 24 | $799.9M | $240.1M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $3.2M |
| 自由现金流经营现金流 - 资本支出 | — | $2.4M |
| 自由现金流率自由现金流/营收 | — | 3.2% |
| 资本支出强度资本支出/营收 | — | 1.2% |
| 现金转化率经营现金流/净利润 | — | 0.03× |
| 过去12个月自由现金流最近4个季度 | — | $16.0M |
8季度趋势，按日历期对齐
经营现金流AMRNAMSC
| Q1 26 | — | — | ||
| Q4 25 | $15.3M | $3.2M | ||
| Q3 25 | $-12.7M | $6.5M | ||
| Q2 25 | $16.6M | $4.1M | ||
| Q1 25 | $-12.5M | $6.3M | ||
| Q4 24 | $-13.3M | $5.9M | ||
| Q3 24 | $-2.4M | $12.7M | ||
| Q2 24 | $-2.7M | $3.4M |
自由现金流AMRNAMSC
| Q1 26 | — | — | ||
| Q4 25 | — | $2.4M | ||
| Q3 25 | — | $5.1M | ||
| Q2 25 | — | $3.3M | ||
| Q1 25 | — | $5.3M | ||
| Q4 24 | — | $5.3M | ||
| Q3 24 | — | $12.1M | ||
| Q2 24 | — | $3.1M |
自由现金流率AMRNAMSC
| Q1 26 | — | — | ||
| Q4 25 | — | 3.2% | ||
| Q3 25 | — | 7.7% | ||
| Q2 25 | — | 4.6% | ||
| Q1 25 | — | 7.9% | ||
| Q4 24 | — | 8.7% | ||
| Q3 24 | — | 22.3% | ||
| Q2 24 | — | 7.8% |
资本支出强度AMRNAMSC
| Q1 26 | — | — | ||
| Q4 25 | — | 1.2% | ||
| Q3 25 | — | 2.1% | ||
| Q2 25 | — | 1.1% | ||
| Q1 25 | — | 1.6% | ||
| Q4 24 | — | 0.9% | ||
| Q3 24 | — | 1.1% | ||
| Q2 24 | — | 0.7% |
现金转化率AMRNAMSC
| Q1 26 | — | — | ||
| Q4 25 | — | 0.03× | ||
| Q3 25 | — | 1.37× | ||
| Q2 25 | — | 0.61× | ||
| Q1 25 | — | 5.22× | ||
| Q4 24 | — | 2.38× | ||
| Q3 24 | — | 2.60× | ||
| Q2 24 | -1.81× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
AMRN
| U.S | $35.6M | 79% |
| Europe | $4.9M | 11% |
| Rest-of-World (ROW) | $2.8M | 6% |
| Licensing & Royalties | $1.8M | 4% |
AMSC
| Equipment And Systems | $56.0M | 75% |
| Megatran | $14.1M | 19% |
| Comtrafo Industria De Transformadores Eletricos SA | $4.6M | 6% |
